Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT00006015

Public ClinicalTrials.gov record NCT00006015. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 1:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study Evaluating the Combination of 5-Fluorouracil, Leucovorin, Oxaliplatin, and Herceptin in the Treatment of Patients With Metastatic Colorectal Cancer Who Have Progressed After 5-FU and/or Irinotecan-Containing Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: This phase II trial is studying combination chemotherapy plus trastuzumab to see how well it works in treating patients with advanced, recurrent, or metastatic colorectal cancer.

Study identification

NCT ID
NCT00006015
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
26 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2000 (Type not available)
Primary completion
Dec 2002 (Actual)
Completion
Feb 2003 (Actual)
Last update posted
May 3, 2013

2000 – 2003

United States locations

U.S. sites
47
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Veterans Affairs Medical Center - Birmingham Birmingham Alabama 35233-1996 —
University of California San Diego Cancer Center La Jolla California 92093-0658 —
Veterans Affairs Medical Center - San Francisco San Francisco California 94121 —
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128 —
CCOP - Christiana Care Health Services Wilmington Delaware 19899 —
Lombardi Cancer Center Washington D.C. District of Columbia 20007 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000 —
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140 —
Veterans Affairs Medical Center - Chicago (Westside Hospital) Chicago Illinois 60612 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Hematology Oncology Associates of the Quad Cities Bettendorf Iowa 52722 —
Holden Comprehensive Cancer Center Iowa City Iowa 52242-1009 —
Veterans Affairs Medical Center - Togus Togus Maine 04330 —
Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
University of Massachusetts Memorial Medical Center - University Campus Worcester Massachusetts 01655 —
Veterans Affairs Medical Center - Minneapolis Minneapolis Minnesota 55417 —
University of Minnesota Cancer Center Minneapolis Minnesota 55455 —
Veterans Affairs Medical Center - Columbia (Truman Memorial) Columbia Missouri 65201 —
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198-7680 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Norris Cotton Cancer Center Lebanon New Hampshire 03756-0002 —
Veterans Affairs Medical Center - Buffalo Buffalo New York 14215 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
New York Presbyterian Hospital - Cornell Campus New York New York 10021 —
Mount Sinai Medical Center, NY New York New York 10029 —
State University of New York - Upstate Medical University Syracuse New York 13210 —
Veterans Affairs Medical Center - Syracuse Syracuse New York 13210 —
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. Syracuse New York 13217 —
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295 —
Veterans Affairs Medical Center - Durham Durham North Carolina 27705 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina 27104-4241 —
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1082 —
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240 —
Rhode Island Hospital Providence Rhode Island 02903 —
University of Tennessee Cancer Institute Memphis Tennessee 38103 —
Veterans Affairs Medical Center - Memphis Memphis Tennessee 38104 —
Green Mountain Oncology Group Bennington Vermont 05201 —
Vermont Cancer Center Burlington Vermont 05401-3498 —
Veterans Affairs Medical Center - White River Junction White River Junction Vermont 05009 —
Veterans Affairs Medical Center - Richmond Richmond Virginia 23249 —
MBCCOP - Massey Cancer Center Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006015, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2013 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00006015 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →